Notification of decision to issue a licence on application - posted 5 October 2012
PDF 62 KB
HTML

Questions and Answers
PDF 9 KB
HTML

Risk Assessment and Risk Management Plan (RARMP) Executive Summary
PDF 59 KB
HTML

Risk Assessment and Risk Management Plan (RARMP) Technical Summary
PDF 85 KB
HTML

Full Risk Assessment and Risk Management Plan (RARMP) for the limited and controlled release of genetically modified live viral vaccines against prostate cancer
PDF 538 KB
HTML

Licence Application Summary
PDF 170 KB
HTML

GM Viral Vaccine Licence Conditions
PDF 350 KB
HTML



Reference material

Risk Analysis Framework for Licence Applications to the Office of the Gene Technology Regulator (3rd Edition) 2009